Matthew M Erdman

Title: Innovations by Matthew M Erdman

Introduction

Matthew M Erdman is a notable inventor based in Ames, Iowa. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines and diagnostic methods for porcine reproductive and respiratory syndrome virus (PRRSV). With a total of six patents to his name, Erdman's work has the potential to greatly impact the health of swine populations.

Latest Patents

Erdman's latest patents focus on the identification of protective antigenic determinants of PRRSV. The invention relates to a polypeptide of a protective antigenic determinant (PAD polypeptide) of PRRSV and nucleic acids encoding a PAD polypeptide. The PAD polypeptide and nucleic acids encoding a PAD polypeptide are useful in the development of antibodies directed to PAD, vaccines effective in providing protection against PRRSV infection, and diagnostic assays detecting the presence of PAD antibodies generated by a PAD-specific vaccine. The invention also discloses methods of generating antibodies to PAD, for vaccinating a pig to provide protection from PRRSV infections, a method of preparing the vaccine, a method of treating PRRSV infections in a pig, and a method of detecting antibodies to PAD of PRRSV.

Career Highlights

Erdman is affiliated with the Iowa State University Research Foundation, Inc., where he conducts his research and development activities. His work has been instrumental in advancing the understanding and management of PRRSV, a significant concern in the swine industry.

Collaborations

Erdman collaborates with various professionals in his field, including Delbert Linn Harris, to enhance the effectiveness of his research and innovations.

Conclusion

Matthew M Erdman's contributions to veterinary medicine through his innovative patents are paving the way for improved health management in swine. His work exemplifies the importance of research and innovation in addressing critical challenges in animal health.